[Depression following a heart infarct and increased risk of death]

Area of Science:

• Cardiology
• Psychiatry
• Psychoneuroimmunology

Background:

• Depression is a significant risk factor for cardiac mortality, particularly within 18 months following myocardial infarction (MI).
• Post-MI depression is characterized by listlessness and hostility, distinct from general depressed mood.
• Depressed patients post-MI face higher cardiac readmission rates and delayed work resumption.

Purpose of the Study:

• To investigate the relationship between depression and myocardial infarction.
• To explore the underlying pathological stress mechanisms common to both conditions.
• To recommend optimal management strategies for post-MI depression.

Main Methods:

• The study reviews existing literature on depression, myocardial infarction, and their shared risk factors.
• It examines the physiological pathways linking stress, depression, and cardiovascular events.
• Clinical recommendations are based on current evidence regarding antidepressant efficacy and safety in post-MI patients.

Main Results:

• Depression and MI share etiological links through behavioral and emotional risk factors, both being stress-related disorders.
• Pathological stress reactions in these conditions involve immune activation, elevated cortisol, altered serotonin metabolism, and sympathetic overactivity.
• Selective serotonin reuptake inhibitors (SSRIs) are effective and safe for treating post-MI depression, while tricyclic antidepressants (TCAs) are contraindicated due to cardiac risks.

Conclusions:

• Early identification and treatment of post-MI depression are crucial.
• SSRIs represent a safe and effective therapeutic option for this patient group.
• Further research is needed to demonstrate a reduction in cardiac mortality or fatal arrhythmias with antidepressant therapy.